לברסט

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

LETROZOLE 2.5 MG

Saatavilla:

RAFA LABORATORIES LTD

ATC-koodi:

L02BG04

Lääkemuoto:

FILM COATED TABLETS

Antoreitti:

PER OS

Valmistaja:

SIEGFRIED GENERICS ( MALTA) LTD

Terapeuttinen ryhmä:

LETROZOLE

Käyttöaiheet:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Valtuutus päivämäärä:

2012-04-01